Stimcell Energetics (STME) Net Income towards Common Stockholders (QoQ) (2016 - 2024)
Stimcell Energetics (STME) Net Income towards Common Stockholders (QoQ) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -85.00% |
| Feb 29, 2024 | -11.56% |
| Nov 30, 2023 | 21.32% |
| Aug 31, 2023 | 3.06% |
| May 31, 2023 | 32.82% |
| Feb 28, 2023 | 17.26% |
| Nov 30, 2022 | 7.67% |
| Aug 31, 2022 | 4.84% |
| May 31, 2022 | -36.05% |
| Feb 28, 2022 | 32.10% |
| Nov 30, 2021 | 26.48% |
| Aug 31, 2021 | -27.57% |
| May 31, 2021 | -4.82% |
| Feb 28, 2021 | 5.45% |
| Nov 30, 2020 | 5.90% |
| Aug 31, 2020 | 20.10% |
| May 31, 2020 | 2.70% |
| Feb 29, 2020 | 14.72% |
| Nov 30, 2019 | -23.73% |
| Aug 31, 2019 | 79.61% |